Response to: Are there two disjunct episignatures for KMT2B-related disease?

Edoardo Monfrini, Andrea Ciolfi, Marco Ferilli, Marco Tartaglia, Alessio Di Fonzo · 2024

Read Response to: Are there two disjunct episignatures for KMT2B-related disease? by Edoardo Monfrini, Andrea Ciolfi, Marco Ferilli, Marco Tartaglia, Alessio Di Fonzo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631119.txt.

Description

Edoardo Monfrini and co-authors reply to a critic of their work on gene-linked disease patterns, in a letter from 2024. The dispute concerns a gene called KMT2B, which is tied to a movement disorder called dystonia. The critic questioned whether two distinct chemical patterns on DNA go with different sets of variants in the gene.

In their reply, the authors say the critic read their claims more strongly than they were stated. They note that computer tools that judge whether a variant is harmful can miss real effects, above all in adult-onset disease. They give examples from Parkinson's disease where known risk variants are wrongly called benign. The letter walks through each concern in turn and defends the care taken in the first study. It aims to clear up confusion for other readers.

Catalog record

CREATOREdoardo Monfrini, Andrea Ciolfi, Marco Ferilli, Marco Tartaglia, Alessio Di Fonzo
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE5 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11631119

Browse the full library · About the Tower of Babel